Publications Office of the EU
Case T-181/23: Judgment of the General Court of 15 May 2024 – Dermavita Company v EUIPO – Allergan Holdings France (JUVÉDERM) (EU trade mark – Invalidity proceedings – EU word mark JUVÉDERM – Absolute ground for invalidity – No bad faith – Article 51(1)(b) of Regulation (EC) No 40/94 (now Article 59(1)(b) of Regulation (EU) 2017/1001))
DisplayCustomHeader
MyPortal
English
BasketSummary
Web Content Display (Global)
Publication Detail Actions Portlet

Utilities

Publication Detail Actions Portlet
 Rate this publication
custom-survey-notification
Publication Detail Portlet

Publication detail

Home

Case T-181/23: Judgment of the General Court of 15 May 2024 – Dermavita Company v EUIPO – Allergan Holdings France (JUVÉDERM) (EU trade mark – Invalidity proceedings – EU word mark JUVÉDERM – Absolute ground for invalidity – No bad faith – Article 51(1)(b) of Regulation (EC) No 40/94 (now Article 59(1)(b) of Regulation (EU) 2017/1001))

Publication metadata

ISSN 1977-091X
Catalogue number FXC2403914EN
pdfa2a
ISSN 1977-091X ISBN DOI Catalogue number FXC2403914EN
Publication Viewer

Document viewer

Pop up window annotations